← All updates
Observational study

Neurology · 28 Oct

Motor Phenotypes Identify Distinct Progression Patterns in ALS

A multicenter cohort study of 1,307 people with amyotrophic lateral sclerosis (ALS) assessed whether anatomically defined motor phenotypes were associated with progression, serum neurofilament light chain (NfL), and survival. Early spread to a vertically distant body region was associated with faster progression, higher NfL, and shorter survival.

Researchers classified 1,307 patients with ALS by region of onset, timing of spread to a vertically distant body region, and the balance of upper and lower motor neuron dysfunction. They compared phenotype associations with ALS progression rate (ALSPR), serum NfL, and survival, and assessed consistency across participating centers. Classification consistency was high, with Kendall’s W ranging from 0.75 to 0.89.

Onset phenotypes were associated with progression rate, NfL, and survival (p<0.001). Early propagation, defined as spread within 12 months, was the strongest marker of disease aggressiveness: it was associated with higher progression rates, elevated NfL, and reduced survival (hazard ratio 2.93; p<0.001). Balanced upper/lower motor neuron involvement and predominant lower motor neuron involvement were also associated with shorter survival (hazard ratio 2.51; p<0.001). Trunk-onset disease showed the lowest log(NfL/ALSPR), while early propagation showed a relative mismatch between NfL and functional decline.

The findings suggest that structured motor phenotyping may help refine prognostic models and trial stratification. The abstract provides no details on cohort recruitment, follow-up duration, or adjustment variables; these prognostic associations do not establish that phenotyping changes treatment or outcomes.

In practice

In this multicenter cohort of 1,307 people with ALS, spread to a vertically distant body region within 12 months was associated with faster progression, higher serum NfL, and shorter survival (HR 2.93). Balanced upper/lower motor neuron dysfunction and predominant lower motor neuron involvement were also associated with shorter survival. These findings support the potential use of structured phenotyping in prognosis and trial stratification, but they do not show that changing clinical management based on phenotype improves outcomes. The abstract does not provide follow-up or adjustment details.

AI-generated clinical interpretation · Not editor-reviewed

AI summary · Not yet editor-reviewed

Is this summary clinically accurate?

Help fellow clinicians: your rating sends inaccurate summaries straight to our editors.

Sign in to rate this summary →

Source

European Journal of Neurology: Anatomically Defined Motor Phenotypes Reveal Dissociated Trajectories of Progression, Neurofilament Profiles, and Survival in ALS ↗

This is an automated AI-condensed summary that has not yet been reviewed by an editor. Always consult the full item at the original source.